Kivu Bioscience
San Francisco
About Kivu Bioscience
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $92.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: kivubioscience.com
Industries & Categories
Biotechnology, Health Care, Oncology
Social Profiles
Canonical: https://fsome.com/organization/kivu-bioscience-18618 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.